INS and fatty liver disease: During DPP4 deficiency (inhibition or a knockout in mice), the sensitivity of pancreatic β-cells to this hormone may diminish, and as a result, insulin secretion may decrease, which, along with the action of glucagon and fatty liver disease, raises blood glucose levels [32].